|
International Webinar - Eradicate hep C in OST setting |
|
Wednesday 13th September 2017
NSW/TAS/ACT/QLD/VIC: 7.30pm - 9.00pm
SA/NT: 7.00pm - 8.30pm
WA: 5.30pm - 7.00pm
|
|
Learning Objectives
After attending this webinar, you should be able to:
- Identify barriers and drivers of HCV treatment in the drug and alcohol setting
- Implement practical steps to simplify the HCV treatment process
- Understand the available HCV treatment options and considerations for optimising individualised treatment.
|
|
|
| Professor Robert Gish
|
| Prof. Gish is a world-renowned hepatologist and is a consulting clinical professor of Medicine at Stanford University (Consultant), Senior Medical Director at Medical Center in Phoenix, and Medical Director at La Maestra in San Diego. He is also part of the leadership groups of the National Viral Hepatitis Roundtable, Hepatitis B Foundation and Vietnam Viral Hepatitis Alliance, in addition to running his own consulting firm.
|
|
|
| Professor Paul Haber
|
| Paul Haber is a physician specializing in addiction medicine and gastroenterology / hepatology. He is Clinical Director for Drug Health Services for the Sydney Local Health District and has been a consultant at Royal Prince Alfred Hospital since 1998. He is a Foundation Fellow and past President of the Royal Australasian College of Physicians Chapter of Addiction Medicine, and a conjoint Professor at the University of Sydney. His research interests focus on health problems related to substance use particularly liver disease.
|
|
|
|